Argenx Se (ARGX) Operating Margin Growth (5y) (2021 - 2026)
Powered by 
Analysis
Argenx Se (ARGX) Operating Margin Growth (5y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | BioNTech SE | 26.24 Bn | 12.58 Bn | 10.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6,996.00 |
| Mar 31, 2026 | 3,036.00 |
| Dec 31, 2025 | -1.13 Mn |
| Sep 30, 2025 | 135,474.00 |
| Jun 30, 2025 | 928,274.00 |
| Mar 31, 2025 | 52,121.00 |
| Dec 31, 2024 | 44,322.00 |
| Sep 30, 2024 | 56,236.00 |
| Jun 30, 2024 | 67,456.00 |
| Mar 31, 2024 | -688.00 |
| Dec 31, 2023 | 218,190.00 |
| Sep 30, 2023 | 106,245.00 |
| Jun 30, 2023 | 5,318.00 |
| Mar 31, 2023 | 20,638.00 |
| Dec 31, 2022 | 38,958.00 |
| Sep 30, 2022 | -49,758.00 |
| Jun 30, 2022 | 10,342.00 |
| Mar 31, 2022 | -92,635.00 |
| Dec 31, 2021 | -97,821.00 |
| Sep 30, 2021 | 93,646.00 |